Duchenne Muscular Dystrophy (DMD) Drugs Industry The global duchenne muscular dystrophy drugs market size is expected to reach USD 9.91 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 16.8% from 2024 to 2030. Several factors such as the emergence of mutation-specific therapies, growing target population, and favorable government...